| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 12 1347-1355, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
WG Cance, RJ Craven, M Bergman, L Xu, K Alitalo and ET Liu
Department of Surgery, University of North Carolina at Chapel Hill School of Medicine 27599.
We have identified a new tyrosine kinase from human breast cancer cells called Rak (a Russian word for cancer) that shares 51% identity with c-Src. Sequencing of the full-length complementary DNA revealed that Rak is a tyrosine kinase with a molecular weight of 54,000 that contains SH2 and SH3 domains, as well as tyrosine residues analogous to the autophosphorylation and regulatory tyrosines of the Src family. Biochemical and site-directed mutagenesis analyses revealed that a carboxy-terminal peptide of p54rak was phosphorylated by a cytoplasmic tyrosine kinase (CSK) and that, as in the Src family, it is the COOH-terminal tyrosine that is phosphorylated by CSK. However, there were some properties of Rak that are distinct from Src-like kinases: (a) expression of Rak was predominantly in epithelial-derived cell lines and tissues, especially normal liver and kidney, and cell lines of breast and colon origin; (b) Rak does not harbor the NH2-terminal glycine essential for myristylation and membrane localization; and (c) Rak possesses a putative bipartite nuclear localization signal in the SH2 domain, and subcellular fractionation studies revealed that p54rak resides predominantly in the nucleus. In addition, p54rak was overexpressed in subsets of primary human epithelial tumors, suggesting that p54rak may have a role in human cancer. Thus, Rak is a novel epithelial-associated nuclear tyrosine kinase that may represent a unique subfamily of the Src-related kinases.
This article has been cited by other articles:
![]() |
A. Haegebarth, W. Bie, R. Yang, S. E. Crawford, V. Vasioukhin, E. Fuchs, and A. L. Tyner Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine. Mol. Cell. Biol., July 1, 2006; 26(13): 4949 - 4957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chandrasekharan, T. H. Qiu, N. Alkharouf, K. Brantley, J. B. Mitchell, and E. T. Liu Characterization of Mice Deficient in the Src Family Nonreceptor Tyrosine Kinase Frk/rak Mol. Cell. Biol., July 15, 2002; 22(14): 5235 - 5247. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meric, W.-P. Lee, A. Sahin, H. Zhang, H.-J. Kung, and M.-C. Hung Expression Profile of Tyrosine Kinases in Breast Cancer Clin. Cancer Res., February 1, 2002; 8(2): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Cance, J. E. Harris, M. V. Iacocca, E. Roche, X. Yang, J. Chang, S. Simkins, and L. Xu Immunohistochemical Analyses of Focal Adhesion Kinase Expression in Benign and Malignant Human Breast and Colon Tissues: Correlation with Preinvasive and Invasive Phenotypes Clin. Cancer Res., June 1, 2000; 6(6): 2417 - 2423. [Abstract] [Full Text] |
||||
![]() |
V. Vasioukhin and A. L. Tyner A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation PNAS, December 23, 1997; 94(26): 14477 - 14482. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Lowell and P Soriano Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories. Genes & Dev., August 1, 1996; 10(15): 1845 - 1857. [PDF] |
||||
![]() |
C. Anneren, K. A. Reedquist, J. L. Bos, and M. Welsh GTK, a Src-related Tyrosine Kinase, Induces Nerve Growth Factor-independent Neurite Outgrowth in PC12 Cells through Activation of the Rap1 Pathway. RELATIONSHIP TO Shb TYROSINE PHOSPHORYLATION AND ELEVATED LEVELS OF FOCAL ADHESION KINASE J. Biol. Chem., September 8, 2000; 275(37): 29153 - 29161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |